Freeline Therapeutics Holdings PLC - ESG Rating & Company Profile powered by AI
This SDG assessment for Freeline Therapeutics Holdings PLC indicates its transparency towards the UN Sustainable Development Goals. If you are employed by Freeline Therapeutics Holdings PLC and you would like to use your ESG rating, please get in touch. The assessment of Freeline Therapeutics Holdings PLC leverages data from across the web and also from public filings by Freeline Therapeutics Holdings PLC.
Freeline Therapeutics Holdings PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 6.4 and governance score of 8.0.
7.5
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
| 149 | Virbac SA | 7.6 | High |
| 160 | Freeline Therapeutics Holdings PLC | 7.5 | High |
| 160 | C4X Discovery Holdings PLC | 7.5 | High |
| 160 | Ascentage Pharma Group International | 7.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Freeline Therapeutics Holdings PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC report the average age of the workforce?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC offer flexible work?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC conduct supply chain audits?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose water use targets?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Freeline Therapeutics Holdings PLC have a product recall in the last two years?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Freeline Therapeutics Holdings PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose parental leave metrics?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Freeline Therapeutics Holdings PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose its waste policy?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC report according to TCFD requirements?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose energy use targets?
Sign up for free to unlockDoes Freeline Therapeutics Holdings PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Freeline Therapeutics Holdings PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Freeline Therapeutics Holdings PLC
These potential risks are based on the size, segment and geographies of the company.
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is FLT180a, a gene therapy product candidate that is in Phase 1/2 dose-finding clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in dose-escalating Phase 1/2 clinical trials for the treatment of Fabry disease; FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease; and FLT210, a liver-directed gene therapy product candidate for the treatment of hemophilia A. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.